MARKET

CORV

Correvio Pharma Corp
CORV
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.5284
0.5694
-27.8079
27,793,595.44
About CORV
Correvio Pharma Corp is a Canada-based specialty pharmaceutical company. It provides brands that meet the needs of acute care physicians and patients. It develops, acquires and commercializes brands for the in-hospital, acute care market segment. The following is its portfolio of approved and marketed brands: Xydalba, for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP); Brinavess for the conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as well as Esmocard and Esmocard Lyo, a short-acting betablocker used to control rapid heart rate in a number of cardiovascular indications. Its pipeline of product candidates includes Trevyent, a drug device combination that is designed to deliver treprostinil.
More

CORV News

More
Correvio Obtains Final Order for Plan of Arrangement
CNW Group · 05/21 21:01
Correvio Pharma Reports Obtained Final Order For Plan Of Arrangement For $76M
Benzinga · 05/21 20:03
Merger Arbitrage Mondays - A Large Number Of Rumored Deals But No Cigar
Seeking Alpha - Article · 05/18 13:35
Correvio Announces Results from Annual General and Special Meeting of Securityholders
CNW Group · 05/15 22:55
Will Correvio Pharma (CORV) Report Negative Q1 Earnings? What You Should Know
Correvio (CORV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 05/06 16:30
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
PR Newswire · 05/06 13:00
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
PR Newswire · 05/01 13:00
Correvio Reports ISS Recommends Shareholders Vote For Deal With ADVANZ PHARMA
Benzinga · 05/01 12:08

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of Correvio Pharma Corp stock information, including NASDAQ:CORV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CORV stock methods without spending real money on the virtual paper trading platform.